Global Parkinson's Disease Treatment Market Analysis By Drug Class (Levodopa/Carbidopa, Dopamine Agonists, MAO-B Inhibitors, COMT Inhibitors, Anticholinergics, Adenosine A2A Antagonists, Glutamate Antagonists, Cholinesterase Inhibitors, Others), By Disease Stage (Early-Stage, Advanced-Stage), By Route of Administration (Oral, Subcutaneous, Transdermal, Inhalation), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) By Region and Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2025-2034
- Published date: Oct 2025
- Report ID: 160750
- Number of Pages: 391
- Format:
-
-
-
- AbbVie Inc. Company Profile
- Amgen Inc.
- Teva Pharmaceutical Industries Ltd. Company Profile
- GlaxoSmithKline plc
- Merck & Co. Inc.
- Pfizer Inc Company Profile
- UCB S.A.
- Lundbeck A/S
- Boehringer Ingelheim GmbH
- Sanofi S.A.
- Sunovion Pharmaceuticals Inc.
- Mylan N.V.
- Roche Holding AG Company Profile
- Other key players
Our Clients
✖
Request a Sample Report
We'll get back to you as quickly as possible